Sionna Therapeutics Inc
NASDAQ:SION
Income Statement
Earnings Waterfall
Sionna Therapeutics Inc
Income Statement
Sionna Therapeutics Inc
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(71)
|
(90)
|
(112)
|
(84)
|
(89)
|
|
| Selling, General & Administrative |
(13)
|
(19)
|
(26)
|
(24)
|
(29)
|
|
| Research & Development |
(57)
|
(71)
|
(86)
|
(59)
|
(60)
|
|
| Operating Income |
(71)
N/A
|
(90)
-28%
|
(112)
-24%
|
(84)
+26%
|
(89)
-7%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
8
|
11
|
15
|
12
|
13
|
|
| Total Other Income |
1
|
1
|
1
|
1
|
0
|
|
| Pre-Tax Income |
(62)
N/A
|
(78)
-27%
|
(96)
-23%
|
(71)
+27%
|
(75)
-6%
|
|
| Net Income | ||||||
| Income from Continuing Operations |
(62)
|
(78)
|
(96)
|
(71)
|
(75)
|
|
| Net Income (Common) |
(62)
N/A
|
(78)
-27%
|
(96)
-23%
|
(71)
+27%
|
(75)
-6%
|
|
| EPS (Diluted) |
-1.45
N/A
|
-1.77
-22%
|
-2.18
-23%
|
-1.61
+26%
|
-1.88
-17%
|
|